Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Ju��ni�� ��etina Tanja) .

211 - 220 / 395
Na začetekNa prejšnjo stran18192021222324252627Na naslednjo stranNa konec
211.
Rak dojke
1998, ni določena

Ključne besede: dojke, rak (medicina), patologija, epidemiologija, diagnostika, zdravljenje, rehabilitacija, zborniki
Objavljeno v DiRROS: 10.08.2020; Ogledov: 1864; Prenosov: 597
.pdf Celotno besedilo (5,91 MB)

212.
Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe : a Central European Cooperative Oncology Group analysis
Tanja Čufer, Tudor Ciuleanu, Peter Berzinec, Gabriela Galffy, Marko Jakopović, Jacek Jassem, Dragana Jovanovic, Zhasmina MIhaylova, Gyula Ostoros, Christiane Thallinger, Milada Zemanova, Christoph Zielinski, 2020, izvirni znanstveni članek

Povzetek: Background. Treatment of non-small cell lung cancer (NSCLC) improved substantially in the last decades. Novel targeted and immune-oncologic drugs were introduced into routine treatment. Despite accelerated development and subsequent drug registrations by the European Medicinal Agency (EMA), novel drugs for NSCLC are poorly accessible in Central and Eastern European (CEE) countries. Material and Methods. The Central European Cooperative Oncology Group conducted a survey among experts from 10 CEE countries to provide an overview on the availability of novel drugs for NSCLC and time from registration to reimbursement decision in their countries. Results. Although first-generation epidermal growth factor receptor tyrosine kinase inhibitors were reimbursed and available in all countries, for other registered therapies - even for ALK inhibitors and checkpoint inhibitors in first-line - there were apparent gaps in availability and/or reimbursement. There was a trend for better availability of drugs with longer time from EMA marketing authorization. Substantial differences in access to novel drugs among CEE countries were observed. In general, the availability of drugs is not in accordance with the Magnitude of Clinical Benefit Scale (MCBS), as defined by the European Society for Medical Oncology (ESMO). Time spans between drug registrations and national decisions on reimbursement vary greatly, from less than 3 months in one country to more than 1 year in the majority of countries. Conclusion. The access to novel drugs for NSCLC in CEE countries is suboptimal. To enable access to the most effective compounds within the shortest possible time, reimbursement decisions should be faster and ESMO MCBS should be incorporated into decision making.
Ključne besede: non-small cell lung cancer, treatment, novel drugs, Central Europe, Southeastern Europe
Objavljeno v DiRROS: 24.07.2020; Ogledov: 1910; Prenosov: 1112
.pdf Celotno besedilo (341,24 KB)
Gradivo ima več datotek! Več...

213.
Elevated ozone prevents acquisition of available nitrogen due to smaller root surface area in poplar
Tanja Mrak, Klemen Eler, Ovidiu Badea, Yasutomo Hoshika, Elisa Carrari, Elena Paoletti, Hojka Kraigher, 2020, izvirni znanstveni članek

Povzetek: Aims Poplars are ecologically and economically important tree genus, sensitive to ozone (O3). This study aimed to investigate modifying effects of elevated O3 on poplar root response to nutrient addition. Methods In pot experiment, young trees of an O3-sensitive Oxford poplar clone (Populus maximoviczii Henry x berolinensis Dippel) growing in soil with three levels of P (0, 40 and 80 kg ha-1) and two levels of N (0 and 80 kg ha-1) were exposed to three levels of O3 (ambient - AA, 1.5 x AA, 2.0 x AA) at a free air exposure facility. After one growing season, root biomass, fine root (<2 mm) nutrient concentrations and ratios, and fine root morphology were assessed. Results Nitrogen addition resulted in an up to +100.5% increase in coarse and fine root biomass under AA, and only up to +46.3% increase under 2.0 x AA. Elevated O3 and P addition had a positive effect, while N had a negative effect on P concentrations in fine roots. Nitrogen limitation for root growth expressed as a N:P ratio was more pronounced at elevated O3. Nitrogen addition increased root surface area per soil volume by +78.3% at AA and only by +9.9% at 2.0 x AA. Conclusions Smaller root surface area per soil volume at elevated O3 prevented acquisition of available N, rendering N fertilization of young poplar plantations in such conditions economically and environmentally questionable.
Ključne besede: fine roots, nitrogen, phosphorus, Populusmaximoviczii x berolinensis, ozone, Poplar
Objavljeno v DiRROS: 16.06.2020; Ogledov: 1939; Prenosov: 1063
.pdf Celotno besedilo (775,68 KB)
Gradivo ima več datotek! Več...

214.
Quality of end-of-life care of patients with lymphoma : a retrospective analysis
Tanja Žnidarič, Miha Toplak, Boštjan Zavratnik, Jožica Červek, 2015, objavljeni povzetek znanstvenega prispevka na konferenci

Objavljeno v DiRROS: 15.06.2020; Ogledov: 1747; Prenosov: 478
.pdf Celotno besedilo (138,70 KB)

215.
216.
Sprejem in bivanje na Onkološkem inštitutu v Ljubljani
Marija Velepič, Tanja Čufer, 2002, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid

Objavljeno v DiRROS: 08.06.2020; Ogledov: 1584; Prenosov: 423
.pdf Celotno besedilo (3,95 MB)

217.
Folikularni limfom : vodnik za bolnike
Tanja Južnič Šetina, 2017, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid

Ključne besede: etiologija, komplikacije, recidiv, bolniki, psihološka pomoč
Objavljeno v DiRROS: 04.06.2020; Ogledov: 1955; Prenosov: 580
.pdf Celotno besedilo (1,15 MB)

218.
219.
220.
Informacije za bolnike, zdravljene z dabrafenibom in trametinibom : vodnik za kombinirano zdravljenje
Janja Ocvirk, Martina Reberšek, Marko Boc, Tanja Mesti, 2019, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid

Ključne besede: onkologija, kemoterapija, kombinirano zdravljenje
Objavljeno v DiRROS: 03.06.2020; Ogledov: 1545; Prenosov: 378
.pdf Celotno besedilo (289,85 KB)

Iskanje izvedeno v 0.37 sek.
Na vrh